MGX-308

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMGX-308
Drug Alias NameMGX-308
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMigraine DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMigco Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMigco Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMigraine DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A